Barrington lowered the firm’s price target on Cross Country Healthcare to $24 from $26 and keeps an Outperform rating on the shares following the company’s recent report of Q4 results and softer market conditions that impacted its Q1 guidance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CCRN:
- Cross Country Healthcare Issues Non-Binding Regulatory Update
- Cross Country Healthcare price target lowered to $16 from $20 at BofA
- Cross Country Healthcare price target lowered to $21 from $24 at Benchmark
- Cross Country Healthcare CCO Daniel White Exits
- Cross Country Healthcare Shares Informal Investor Update
